1
|
Hervieu C, Verdier M, Barthout E, Bégaud G, Christou N, Sage M, Pannequin J, Battu S, Mathonnet M. A Label-Free Cell Sorting Approach to Highlight the Impact of Intratumoral Cellular Heterogeneity and Cancer Stem Cells on Response to Therapies. Cells 2022; 11:2264. [PMID: 35892561 PMCID: PMC9332486 DOI: 10.3390/cells11152264] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Revised: 07/15/2022] [Accepted: 07/20/2022] [Indexed: 02/01/2023] Open
Abstract
Cancer stem cells play a crucial role in tumor initiation, metastasis, and resistance to treatment. Cellular heterogeneity and plasticity complicate the isolation of cancer stem cells. The impact of intra-tumor cellular heterogeneity using a label-free approach remains understudied in the context of treatment resistance. Here, we use the sedimentation field-flow fractionation technique to separate, without labeling, cell subpopulations of colorectal cancer cell lines and primary cultures according to their biophysical properties. One of the three sorted cell subpopulations exhibits characteristics of cancer stem cells, including high tumorigenicity in vivo and a higher frequency of tumor-initiating cells compared to the other subpopulations. Due to its chemoresistance, two- and three-dimensional in vitro chemosensitivity assays highlight the therapeutic relevance of this cancer stem cell subpopulation. Thus, our results reveal the major implication of intra-tumor cellular heterogeneity, including cancer stem cells in treatment resistance, thanks to our label-free cell sorting approach. This approach enables-by breaking down the tumor-the study the individualized response of each sorted tumor cell subpopulation and to identify chemoresistance, thus offering new perspectives for personalized therapy.
Collapse
Affiliation(s)
- Céline Hervieu
- UMR INSERM 1308-CAPTuR “Control of Cell Activation in Tumor Progression and Therapeutic Resistance”, Ω-Health Institute, Faculty of Medicine, University of Limoges, 87025 Limoges, France; (C.H.); (M.V.); (E.B.); (G.B.); (N.C.); (S.B.)
| | - Mireille Verdier
- UMR INSERM 1308-CAPTuR “Control of Cell Activation in Tumor Progression and Therapeutic Resistance”, Ω-Health Institute, Faculty of Medicine, University of Limoges, 87025 Limoges, France; (C.H.); (M.V.); (E.B.); (G.B.); (N.C.); (S.B.)
| | - Elodie Barthout
- UMR INSERM 1308-CAPTuR “Control of Cell Activation in Tumor Progression and Therapeutic Resistance”, Ω-Health Institute, Faculty of Medicine, University of Limoges, 87025 Limoges, France; (C.H.); (M.V.); (E.B.); (G.B.); (N.C.); (S.B.)
| | - Gaëlle Bégaud
- UMR INSERM 1308-CAPTuR “Control of Cell Activation in Tumor Progression and Therapeutic Resistance”, Ω-Health Institute, Faculty of Medicine, University of Limoges, 87025 Limoges, France; (C.H.); (M.V.); (E.B.); (G.B.); (N.C.); (S.B.)
| | - Niki Christou
- UMR INSERM 1308-CAPTuR “Control of Cell Activation in Tumor Progression and Therapeutic Resistance”, Ω-Health Institute, Faculty of Medicine, University of Limoges, 87025 Limoges, France; (C.H.); (M.V.); (E.B.); (G.B.); (N.C.); (S.B.)
- Department of General, Endocrine and Digestive Surgery, University Hospital of Limoges, 87025 Limoges, France
| | - Magali Sage
- BISCEm US42 INSERM-UAR 2015 CNRS “Integrative Biology Health Chemistry Environment”, Ω-Health Institute, 87025 Limoges, France;
| | - Julie Pannequin
- UMR 5203 CNRS-INSERM, Institute of Functional Genomics, University of Montpellier, 34094 Montpellier, France;
| | - Serge Battu
- UMR INSERM 1308-CAPTuR “Control of Cell Activation in Tumor Progression and Therapeutic Resistance”, Ω-Health Institute, Faculty of Medicine, University of Limoges, 87025 Limoges, France; (C.H.); (M.V.); (E.B.); (G.B.); (N.C.); (S.B.)
| | - Muriel Mathonnet
- UMR INSERM 1308-CAPTuR “Control of Cell Activation in Tumor Progression and Therapeutic Resistance”, Ω-Health Institute, Faculty of Medicine, University of Limoges, 87025 Limoges, France; (C.H.); (M.V.); (E.B.); (G.B.); (N.C.); (S.B.)
- Department of General, Endocrine and Digestive Surgery, University Hospital of Limoges, 87025 Limoges, France
| |
Collapse
|
2
|
Saydé T, Manczak R, Saada S, Bégaud G, Bessette B, Lespes G, Le Coustumer P, Gaudin K, Dalmay C, Pothier A, Lalloué F, Battu S. Characterization of Glioblastoma Cancer Stem Cells Sorted by Sedimentation Field-Flow Fractionation Using an Ultrahigh-Frequency Range Dielectrophoresis Biosensor. Anal Chem 2021; 93:12664-12671. [PMID: 34491042 DOI: 10.1021/acs.analchem.1c02466] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Cancer stem cells (CSCs) appear to be an essential target for cancer therapies, in particular, in brain tumors such as Glioblastoma. Nevertheless, their isolation is made difficult by their low content in culture or tumors (<5% of the tumor mass) and is essentially based on the use of fluorescent or magnetic labeling techniques, increasing the risk of differentiation induction. The use of label-free separation methods such as sedimentation field-flow fractionation (SdFFF) is promising, but it becomes necessary to consider a coupling with a detection and characterization method for future identification and purification of CSCs from patient-derived tumors. In this study, we demonstrate for the first time the capability of using an ultrahigh-frequency range dielectrophoresis fluidic biosensor as a detector. This implies an important methodological adaptation of SdFFF cell sorting by the use of a new compatible carrier liquid DEP buffer (DEP-B). After SdFFF sorting, subpopulations derived from U87-MG and LN18 cell lines undergo biological characterization, demonstrating that using DEP-B as a carrier liquid, we sorted by SdFFF subpopulations with specific differentiation characteristics: F1 = differentiated cells/F2 = CSCs. These subpopulations presented high-frequency crossover (HFC) values similar to those measured for standard differentiated (around 110 MHz) and CSC (around 80 MHz) populations. This coupling appeared as a promising solution for the development of an online integration of these two complementary label-free separation/detection technologies.
Collapse
Affiliation(s)
- Tarek Saydé
- EA3842-CAPTuR, GEIST, Faculté de Médecine, Université de Limoges, 2 rue du Dr Marcland, Limoges 87025, France.,ARNA, INSERM U1212, UMR CNRS 5320, Université de Bordeaux, 146 rue Léo Saignat, Bordeaux 33076, France
| | - Rémi Manczak
- XLIM-UMR CNRS 7252, Université de Limoges, 123, avenue Albert Thomas, Limoges 87060 LIMOGES CEDEX, France
| | - Sofiane Saada
- EA3842-CAPTuR, GEIST, Faculté de Médecine, Université de Limoges, 2 rue du Dr Marcland, Limoges 87025, France
| | - Gaelle Bégaud
- EA3842-CAPTuR, GEIST, Faculté de Médecine, Université de Limoges, 2 rue du Dr Marcland, Limoges 87025, France
| | - Barbara Bessette
- EA3842-CAPTuR, GEIST, Faculté de Médecine, Université de Limoges, 2 rue du Dr Marcland, Limoges 87025, France
| | - Gaëtane Lespes
- CNRS, Institut des Sciences Analytiques et de Physico-Chimie pour l'Environnement et les Matériaux (IPREM), UMR 5254, Université de Pau et des Pays de l'Adour (E2S/UPPA), 2 Avenue Pierre Angot, Pau 64053, France
| | - Philippe Le Coustumer
- Bordeaux Imaging Center, UMS 3420 CNRS-INSERM, Université de Bordeaux, 146 rue Léo Saignat, Bordeaux 33076, France
| | - Karen Gaudin
- ARNA, INSERM U1212, UMR CNRS 5320, Université de Bordeaux, 146 rue Léo Saignat, Bordeaux 33076, France
| | - Claire Dalmay
- XLIM-UMR CNRS 7252, Université de Limoges, 123, avenue Albert Thomas, Limoges 87060 LIMOGES CEDEX, France
| | - Arnaud Pothier
- XLIM-UMR CNRS 7252, Université de Limoges, 123, avenue Albert Thomas, Limoges 87060 LIMOGES CEDEX, France
| | - Fabrice Lalloué
- EA3842-CAPTuR, GEIST, Faculté de Médecine, Université de Limoges, 2 rue du Dr Marcland, Limoges 87025, France
| | - Serge Battu
- EA3842-CAPTuR, GEIST, Faculté de Médecine, Université de Limoges, 2 rue du Dr Marcland, Limoges 87025, France
| |
Collapse
|
3
|
Plavchak CL, Smith WC, Bria CRM, Williams SKR. New Advances and Applications in Field-Flow Fractionation. ANNUAL REVIEW OF ANALYTICAL CHEMISTRY (PALO ALTO, CALIF.) 2021; 14:257-279. [PMID: 33770457 DOI: 10.1146/annurev-anchem-091520-052742] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Field-flow fractionation (FFF) is a family of techniques that was created especially for separating and characterizing macromolecules, nanoparticles, and micrometer-sized analytes. It is coming of age as new nanomaterials, polymers, composites, and biohybrids with remarkable properties are introduced and new analytical challenges arise due to synthesis heterogeneities and the motivation to correlate analyte properties with observed performance. Appreciation of the complexity of biological, pharmaceutical, and food systems and the need to monitor multiple components across many size scales have also contributed to FFF's growth. This review highlights recent advances in FFF capabilities, instrumentation, and applications that feature the unique characteristics of different FFF techniques in determining a variety of information, such as averages and distributions in size, composition, shape, architecture, and microstructure and in investigating transformations and function.
Collapse
Affiliation(s)
- Christine L Plavchak
- Laboratory for Advanced Separation Technologies, Department of Chemistry, Colorado School of Mines, Golden, Colorado 80401, USA;
| | - William C Smith
- Laboratory for Advanced Separation Technologies, Department of Chemistry, Colorado School of Mines, Golden, Colorado 80401, USA;
| | | | - S Kim Ratanathanawongs Williams
- Laboratory for Advanced Separation Technologies, Department of Chemistry, Colorado School of Mines, Golden, Colorado 80401, USA;
| |
Collapse
|
4
|
Mélin C, Perraud A, Christou N, Bibes R, Cardot P, Jauberteau MO, Battu S, Mathonnet M. New ex-ovo colorectal-cancer models from different SdFFF-sorted tumor-initiating cells. Anal Bioanal Chem 2015; 407:8433-43. [PMID: 26427501 DOI: 10.1007/s00216-015-9029-z] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2015] [Revised: 08/25/2015] [Accepted: 09/04/2015] [Indexed: 01/27/2023]
Abstract
Despite effective treatments, relapse of colorectal cancer (CRC) is frequent, in part caused by the existence of tumor-initiating cells (TICs). Different subtypes of TICs, quiescent and activated, coexist in tumors, defining the tumor aggressiveness and therapeutic response. These subtypes have been sorted by hyperlayer sedimentation field-flow fractionation (SdFFF) from WiDr and HCT116 cell lines. On the basis of a new strategy, including TIC SdFFF sorting, 3D Matrigel amplification, and grafting of corresponding TIC colonies on the chick chorioallantoic membrane (CAM), specific tumor matrices could be obtained. If tumors had similar architectural structure with vascularization by the host system, they had different proliferative indices in agreement with their initial quiescent or activated state. Protein analysis also revealed that tumors obtained from a population enriched for "activated" TICs lost "stemness" properties and became invasive. In contrast, tumors obtained from a population enriched for "quiescent" TICs kept their stemness properties and seemed to be less proliferative and invasive. Then, it was possible to produce different kinds of tumor which could be used as selective supports to study carcinogenesis and therapy sensitivity.
Collapse
Affiliation(s)
- Carole Mélin
- Université de Limoges, Laboratoire EA 3842, Homéostasie cellulaire et Pathologies, Faculté de Médecine et de Pharmacie, 2 rue du Dr Marcland, 87025, Limoges cedex, France.,Université de Limoges, Institut Fédératif de Recherche 145 GEIST « Génomique, Environnement, Immunité, Santé et Thérapeutiques », 2 rue du Dr Marcland, 87025, Limoges cedex, France
| | - Aurélie Perraud
- Université de Limoges, Laboratoire EA 3842, Homéostasie cellulaire et Pathologies, Faculté de Médecine et de Pharmacie, 2 rue du Dr Marcland, 87025, Limoges cedex, France.,Université de Limoges, Institut Fédératif de Recherche 145 GEIST « Génomique, Environnement, Immunité, Santé et Thérapeutiques », 2 rue du Dr Marcland, 87025, Limoges cedex, France.,CHU de Limoges, Service de chirurgie digestive générale et endocrinienne, 2 rue Martin Luther King, 87042, Limoges cedex, France
| | - Niki Christou
- Université de Limoges, Laboratoire EA 3842, Homéostasie cellulaire et Pathologies, Faculté de Médecine et de Pharmacie, 2 rue du Dr Marcland, 87025, Limoges cedex, France.,Université de Limoges, Institut Fédératif de Recherche 145 GEIST « Génomique, Environnement, Immunité, Santé et Thérapeutiques », 2 rue du Dr Marcland, 87025, Limoges cedex, France.,CHU de Limoges, Service de chirurgie digestive générale et endocrinienne, 2 rue Martin Luther King, 87042, Limoges cedex, France
| | - Romain Bibes
- Université de Limoges, Laboratoire EA 3842, Homéostasie cellulaire et Pathologies, Faculté de Médecine et de Pharmacie, 2 rue du Dr Marcland, 87025, Limoges cedex, France.,Université de Limoges, Institut Fédératif de Recherche 145 GEIST « Génomique, Environnement, Immunité, Santé et Thérapeutiques », 2 rue du Dr Marcland, 87025, Limoges cedex, France
| | - Philippe Cardot
- Université de Limoges, Institut Fédératif de Recherche 145 GEIST « Génomique, Environnement, Immunité, Santé et Thérapeutiques », 2 rue du Dr Marcland, 87025, Limoges cedex, France.,Université de Limoges, Laboratoire de Chimie Analytique, EA 3842, "Homéostasie Cellulaire et Pathologies", Faculté de Médecine et de Pharmacie, 2 rue du Docteur Marcland, 87025, Limoges Cedex, France
| | - Marie-Odile Jauberteau
- Université de Limoges, Laboratoire EA 3842, Homéostasie cellulaire et Pathologies, Faculté de Médecine et de Pharmacie, 2 rue du Dr Marcland, 87025, Limoges cedex, France.,Université de Limoges, Institut Fédératif de Recherche 145 GEIST « Génomique, Environnement, Immunité, Santé et Thérapeutiques », 2 rue du Dr Marcland, 87025, Limoges cedex, France
| | - Serge Battu
- Université de Limoges, Institut Fédératif de Recherche 145 GEIST « Génomique, Environnement, Immunité, Santé et Thérapeutiques », 2 rue du Dr Marcland, 87025, Limoges cedex, France. .,Université de Limoges, Laboratoire de Chimie Analytique, EA 3842, "Homéostasie Cellulaire et Pathologies", Faculté de Médecine et de Pharmacie, 2 rue du Docteur Marcland, 87025, Limoges Cedex, France.
| | - Muriel Mathonnet
- Université de Limoges, Laboratoire EA 3842, Homéostasie cellulaire et Pathologies, Faculté de Médecine et de Pharmacie, 2 rue du Dr Marcland, 87025, Limoges cedex, France.,Université de Limoges, Institut Fédératif de Recherche 145 GEIST « Génomique, Environnement, Immunité, Santé et Thérapeutiques », 2 rue du Dr Marcland, 87025, Limoges cedex, France.,CHU de Limoges, Service de chirurgie digestive générale et endocrinienne, 2 rue Martin Luther King, 87042, Limoges cedex, France
| |
Collapse
|